# Astrid Botty van den Bruele

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/astrid-botty-van-den-bruele/

## Facts

| Field | Value |
| --- | --- |
| Citations | 582 |
| Field | Breast Cancer Treatment Studies |
| h-index | 13 |
| i10-index | 16 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5051813315 |
| Works | 66 |

## Researcher papers

- [Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy](https://scholariq.org/papers/omission-of-axillary-dissection-following-nodal-downstaging-with-neoadjuvant/)
- [Sound preconditioning therapy inhibits ototoxic hearing loss in mice](https://scholariq.org/papers/sound-preconditioning-therapy-inhibits-ototoxic-hearing-loss-in-mice/)
- [Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study](https://scholariq.org/papers/nodal-burden-and-oncologic-outcomes-in-patients-with-residual-isolated-tumor/)
- [Elder Abuse](https://scholariq.org/papers/elder-abuse/)
- [Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program](https://scholariq.org/papers/mobile-mammography-in-new-york-city-analysis-of-32-350-women-utilizing-a/)
- [Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy](https://scholariq.org/papers/omission-of-axillary-lymph-node-dissection-in-patients-with-residual-nodal/)
- [Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy](https://scholariq.org/papers/racial-ethnic-disparities-in-pathologic-complete-response-and-overall-survival/)
- [Salvage of locally recurrent breast cancer with repeat breast conservation using 45 Gy hyperfractionated partial breast re-irradiation](https://scholariq.org/papers/salvage-of-locally-recurrent-breast-cancer-with-repeat-breast-conservation-using/)
- [Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks](https://scholariq.org/papers/society-of-surgical-oncology-breast-disease-site-working-group-statement-on/)
- [Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study](https://scholariq.org/papers/oncological-outcomes-with-and-without-axillary-lymph-node-dissection-in-patients/)
- [Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy](https://scholariq.org/papers/management-of-ipsilateral-breast-tumor-recurrence-following-breast-conservation/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Breast Implant and Reconstruction](https://scholariq.org/topics/breast-implant-and-reconstruction/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.